KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Operating Leases (2019 - 2025)

Historic Operating Leases for BeOne Medicines (ONC) over the last 7 years, with Q3 2025 value amounting to $51.4 million.

  • BeOne Medicines' Operating Leases rose 5833.8% to $51.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.4 million, marking a year-over-year increase of 5833.8%. This contributed to the annual value of $44.3 million for FY2024, which is 17.19% up from last year.
  • According to the latest figures from Q3 2025, BeOne Medicines' Operating Leases is $51.4 million, which was up 5833.8% from $53.9 million recorded in Q2 2025.
  • Over the past 5 years, BeOne Medicines' Operating Leases peaked at $65.0 million during Q4 2021, and registered a low of $17.7 million during Q1 2024.
  • For the 5-year period, BeOne Medicines' Operating Leases averaged around $39.9 million, with its median value being $37.6 million (2021).
  • Per our database at Business Quant, BeOne Medicines' Operating Leases crashed by 4554.28% in 2024 and then surged by 20975.62% in 2025.
  • BeOne Medicines' Operating Leases (Quarter) stood at $65.0 million in 2021, then fell by 9.86% to $58.6 million in 2022, then decreased by 24.52% to $44.2 million in 2023, then rose by 0.17% to $44.3 million in 2024, then grew by 16.06% to $51.4 million in 2025.
  • Its last three reported values are $51.4 million in Q3 2025, $53.9 million for Q2 2025, and $54.9 million during Q1 2025.